Holen Sie sich die Stockscreener-App
11.25
2.65%
0.2899
Handel nachbörslich:
10.91
-0.3399
-3.02%
Envveno Medical Corp Aktie (NVNO) Neueste Nachrichten
enVVeno Medical Q3 2025 Earnings: Narrower Loss Beats Expectations as Clinical Programs AdvanceEarnings Revision Report - Newser
enVVeno Medical (NVNO) Q3 2025 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline ProgressCommunity Hot Stocks - Newser
enVVeno Medical (NVNO) Edges Higher: Analyzing Recent Price Action and Key LevelsWave Truncation - Newser
Perceptive entities disclose 9.99% stake in enVVeno (NASDAQ: NVNO) - Stock Titan
Kingdon group holds 36,166 shares in enVVeno (NASDAQ: NVNO) - Stock Titan
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System - Palm Beach Daily News
Number of shareholders of enVVeno Medical Corporation – NASDAQ:NVNO - TradingView
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment - The Joplin Globe
First-ever U.S. venous valve trial could address DVI in 3M Americans - Stock Titan
TradingKey - TradingKey
What enVVeno (NVNO) is doing that smart investors recognize (-2.26%) 2026-05-08Stock Surge - Newser
enVVeno Medical sees cash runway into 3Q27 - TipRanks
enVVeno Medical says cash burn rate may increase to $4M-$5M per quarter - TipRanks
enVVeno Medical reports Q1 EPS ($5.89) vs. ($7.75) last year - TipRanks
enVVeno Reports Having $25M Cash on Hand in Q1 Earnings - Orange County Business Journal
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System - IndyStar
With $25M on hand, enVVeno moves toward first U.S. venous valve study - Stock Titan
EnVVeno Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
enVVeno Medical (NVNO) trims Q1 loss and secures FDA IDE for pivotal enVVe TAVVE study - Stock Titan
One enVVeno Medical Insider Raised Their Stake In The Previous Year - Yahoo Finance
enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve - MedTech Intelligence
enVVeno Medical secures FDA IDE approval for venous valve study - Medical Device Network
enVVeno Medical (NVNO) Secures FDA IDE Approval for Pivotal Stud - GuruFocus
enVVeno Medical announces FDA awarded IDE approval to proceed with TAVVEB study - TipRanks
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve - BioSpace
enVVeno Medical Wins FDA IDE for TAVVE Trial - TipRanks
enVVeno receives FDA approval for venous valve pivotal trial By Investing.com - Investing.com South Africa
enVVeno receives FDA approval for venous valve pivotal trial - Investing.com
FDA clears enVVeno (NASDAQ: NVNO) pivotal enVVe CVI valve study - Stock Titan
FDA allows first U.S. study of a nonsurgical vein valve for 3M patients - Stock Titan
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Times Reporter
NVNO enVVeno posts narrower than expected Q3 2025 loss, shares register small gains in today’s trading.CEO Statement - Newser
enVVeno (NVNO) Stock Iron Condor (Breakdown Watch) 2026-04-20Volume Breakout Ideas - Newser
MSN Money - MSN
What is enVVeno Medical Corporations market position2026 Price Swings & AI Driven Stock Movement Reports - baoquankhu1.vn
Stop Loss: What is enVVeno Medical Corporations market positionQuarterly Market Review & Technical Entry and Exit Alerts - baoquankhu1.vn
Whats the profit margin of enVVeno Medical Corporation2026 Market Mood & Risk Managed Investment Signals - baoquankhu1.vn
NVNO PE Ratio & Valuation, Is NVNO Overvalued - Intellectia AI
enVVeno Medical Shares Crash After FDA Reaffirms VenoValve Rejection - MSN
Dow Update: Is enVVeno Medical Corporation a strong candidate for buy and holdMarket Trend Report & Consistent Profit Alerts - baoquankhu1.vn
Market Wrap: Whats the MACD signal for enVVeno Medical Corporation2026 Short Interest & Daily Profit Maximizing Tips - baoquankhu1.vn
enVVeno Medical Corp (NVNO) SEC filings - GuruFocus
enVVeno Medical Corp (NVNO) Stock Earnings Transcripts - GuruFocus
enVVeno Medical Reports FY GAAP EPS of -$33.06 Amid Reverse Stock Split - Intellectia AI
Market Pulse: Whats the MACD signal for enVVeno Medical Corporation2026 Technical Patterns & Weekly Top Gainers Alerts - baoquankhu1.vn
AI Models Reiterate High-Risk, Speculative View on enVVeno Medical (NVNO) - TipRanks
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):